Original Article
2018 annual report of thoracic surgery service at Shanghai Chest Hospital
Abstract
Background: The Thoracic Surgery team at the Shanghai Chest Hospital has published its first annual report since 2017, which mainly contained the key achievements in the year before. This second annual report reviewed the efforts and achievements of the Thoracic Surgery service in the year 2018. Continuous effort has been made to further improve our service.
Methods: Patients received thoracic surgeries in 2018 at the Department of Thoracic Surgery and the Department of Thoracic Oncological, Shanghai Chest Hospital, were retrospectively collected. Detailed data on surgical volume, procedures, and peri-operative outcomes, stratified by each specialty, were carefully studied and compared with the results from previous years. Progress in education and research were also reported.
Results: In 2018, 58 thoracic surgeons, including 23 attending surgeons and 35 clinical fellows and residents, performed 14,054 major thoracic surgeries, including 11,958 pulmonary procedures, 866 esophageal procedures, 957 mediastinal procedures, 45 trachea procedures, and 7 lung transplantations. The total volume increased by 13.9% compared with the previous year. Among them, 88.4% were accomplished via minimally invasive approaches, including both video-assisted thoracoscopic/ laparoscopic surgery and robotic surgery. There was a clear trend towards increased use of minimally invasive techniques for more complicated thoracic diseases in each specialty. More importantly, the unplanned reoperation rate, readmission to ICU rate, and 30-day mortality rate were all maintained in an extremely low level, being 0.37%, 0.82% and 0.21%, respectively.
Conclusions: Tremendous effort has been engaged in improving Thoracic Surgery service at the Shanghai Chest Hospital. The year 2018 witnessed not only continuous increase in volume but also persistent high quality and safety in patient care. With these accomplishments and focus on more innovations, we will strive to deliver higher level of medical services in the future.
Methods: Patients received thoracic surgeries in 2018 at the Department of Thoracic Surgery and the Department of Thoracic Oncological, Shanghai Chest Hospital, were retrospectively collected. Detailed data on surgical volume, procedures, and peri-operative outcomes, stratified by each specialty, were carefully studied and compared with the results from previous years. Progress in education and research were also reported.
Results: In 2018, 58 thoracic surgeons, including 23 attending surgeons and 35 clinical fellows and residents, performed 14,054 major thoracic surgeries, including 11,958 pulmonary procedures, 866 esophageal procedures, 957 mediastinal procedures, 45 trachea procedures, and 7 lung transplantations. The total volume increased by 13.9% compared with the previous year. Among them, 88.4% were accomplished via minimally invasive approaches, including both video-assisted thoracoscopic/ laparoscopic surgery and robotic surgery. There was a clear trend towards increased use of minimally invasive techniques for more complicated thoracic diseases in each specialty. More importantly, the unplanned reoperation rate, readmission to ICU rate, and 30-day mortality rate were all maintained in an extremely low level, being 0.37%, 0.82% and 0.21%, respectively.
Conclusions: Tremendous effort has been engaged in improving Thoracic Surgery service at the Shanghai Chest Hospital. The year 2018 witnessed not only continuous increase in volume but also persistent high quality and safety in patient care. With these accomplishments and focus on more innovations, we will strive to deliver higher level of medical services in the future.
